|Bid||0.00 x 900|
|Ask||0.00 x 1000|
|Day's Range||31.11 - 32.11|
|52 Week Range||22.61 - 43.61|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Jim Cramer explains how the market's overreaction in late 2018 has investors feeling a sense of certainty in the new year.
CNBC's Jim Cramer explains how the market’s overreaction in late 2018 has investors feeling a sense of certainty in the new year. The "Mad Money" host also checks in with the CEOs of Kirkland Lake Gold and Appian Corp. In the lightning round, Cramer shares why he thinks GW Pharmaceuticals' stock can go higher.
Zero-debt allows substantial financial flexibility, especially for small-cap companies like Appian Corporation (NASDAQ:APPN), as the company does not have to adhere to strict debt covenants. However, it also faces higher Read More...
Shares of all three companies fell by double digits. Is there something for investors to worry about, or is this just market noise?
Appian (APPN) delivered earnings and revenue surprises of 27.78% and 10.53%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
The world's best investors are always placing bets on the future. Here are three big bets from three great investors that you should know about.
If you want to know who really controls Appian Corporation (NASDAQ:APPN), then you’ll have to look at the makeup of its share registry. Insiders often own a large chunk ofRead More...
Appian (APPN) delivered earnings and revenue surprises of 17.65% and 19.04%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?